Work

Abstract 1762: Preclinical and clinical studies of PEP07, a novel brain penetrating oral Chk1 inhibitor, on AML and MCL treatments

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1762

Authors: Hui-Ling Chen, Chieh-Fang Cheng, Feng-Yu Lee, Cheng-Hao Liu, Hong-Ren Wang

Institution: PharmaEngine, Inc. (Taiwan)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409626196

Cites:

Cited by:

Related to: 10